141 related articles for article (PubMed ID: 35603532)
1. SMARCB1 (INI-1)-Deficient Sinonasal Carcinoma: A Case Report and Literature Review.
Yang H; Zhou L; Zhong G; Li X; Wang Y
Ear Nose Throat J; 2022 May; ():1455613221082622. PubMed ID: 35603532
[No Abstract] [Full Text] [Related]
2. Immunotherapy in SMARCB1 (INI-1)-deficient sinonasal carcinoma: Two case reports.
Zhang L; Gao AX; He YL; Xu MJ; Lu HJ
World J Clin Cases; 2023 Nov; 11(32):7911-7919. PubMed ID: 38073679
[TBL] [Abstract][Full Text] [Related]
3. [Analysis of the diagnosis and treatment of patients with SMARCB1 (INI-1)-deficient sinonasal carcinoma].
Wang LW; Wang R; Fang JG; Zhong LZ; Hou HZ; Ma L; Feng SZ; He CS; Wang L; Zhang L
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2022 Jul; 57(7):848-853. PubMed ID: 35866278
[No Abstract] [Full Text] [Related]
4. SMARCB1(INI-1)-Deficient Sinonasal Carcinoma: An Evolving Entity.
Chung SY; Kenee P; Mitton T; Halderman A
J Neurol Surg Rep; 2023 Jan; 84(1):e1-e5. PubMed ID: 36712411
[TBL] [Abstract][Full Text] [Related]
5. SMARCB1-Deficient Sinonasal Carcinoma: Systematic Review and Case Report.
Parsel SM; Jawad BA; McCoul ED
World Neurosurg; 2020 Apr; 136():305-310. PubMed ID: 32001406
[TBL] [Abstract][Full Text] [Related]
6. SMARCB1-deficient sinonasal carcinoma: a case report and literature review.
Yanagawa N; Suzuki M; Sugimoto R; Osakabe M; Uesugi N; Shiga K; Sugai T
J Surg Case Rep; 2021 Apr; 2021(4):rjab161. PubMed ID: 33959255
[TBL] [Abstract][Full Text] [Related]
7. Clinical Diagnosis and Treatment Analyses on SMARCB1 (Integrase Interactor 1)-Deficient Sinonasal Carcinoma: Case Series with Systematic Review of the Literature.
Wang R; Wang L; Fang J; Zhong Q; Hou L; Ma H; Feng L; He S; Wang C; Zhang L
World Neurosurg; 2022 May; 161():e229-e243. PubMed ID: 35123020
[TBL] [Abstract][Full Text] [Related]
8. Metastatic SMARCB1 (INI-1)-Deficient Sinonasal Carcinoma Diagnosed by Endobronchial Ultrasound-Guided Fine-Needle Aspiration (EBUS-FNA): A Potential Diagnostic Pitfall and Review of the Literature.
McHugh KE; Policarpio-Nicolas MLC
Acta Cytol; 2019; 63(5):431-437. PubMed ID: 31132763
[TBL] [Abstract][Full Text] [Related]
9. SMARCB1-Deficient Sinonasal Carcinoma: A Case Report and Discussion of the Clinical Implications.
Trieu V; Aulet RM; Ciolino A; Rimash T
Ann Otol Rhinol Laryngol; 2019 Jul; 128(7):676-680. PubMed ID: 30873845
[TBL] [Abstract][Full Text] [Related]
10. [Clinicopathological characteristics of SMARCB1(INI1)-deficient sinonasal carcinoma].
Wang JY; Bai YP; Xing L; Piao YS; He XJ; Yue CL; Zhao XL; Liu HG
Zhonghua Bing Li Xue Za Zhi; 2021 Nov; 50(11):1240-1245. PubMed ID: 34719161
[No Abstract] [Full Text] [Related]
11. Loss of
Chitguppi C; Rabinowitz MR; Johnson J; Bar-Ad V; Fastenberg JH; Molligan J; Berman E; Nyquist GG; Rosen MR; Evans JE; Mardekian SK
J Neurol Surg B Skull Base; 2020 Dec; 81(6):610-619. PubMed ID: 33381364
[No Abstract] [Full Text] [Related]
12. SMARCB1 (INI-1)-Deficient Adenocarcinoma of the Sinonasal Tract: A Potentially Under-Recognized form of Sinonasal Adenocarcinoma with Occasional Yolk Sac Tumor-Like Features.
Shah AA; Jain D; Ababneh E; Agaimy A; Hoschar AP; Griffith CC; Magliocca KR; Wenig BM; Rooper LM; Bishop JA
Head Neck Pathol; 2020 Jun; 14(2):465-472. PubMed ID: 31468350
[TBL] [Abstract][Full Text] [Related]
13. Clinical Benefit to an Aurora A Kinase Inhibitor in a Patient with Metastatic Integrase Interactor 1-Deficient Carcinoma.
Karantanos T; Rooper L; Kang Y; Lin CT; Wenga P; Sagorsky S; Lauring J; Kang H
Oncologist; 2019 Feb; 24(2):146-150. PubMed ID: 30297384
[TBL] [Abstract][Full Text] [Related]
14. Case Report: SMARCB1 (INI-1)-Deficient Carcinoma of the Nasal Cavity with Pure Yolk Sac Tumor Differentiation and Elevated Serum AFP Levels.
Li CY; Han YM; Xu K; Wu SY; Lin XY; Cao HY
Onco Targets Ther; 2021; 14():2227-2233. PubMed ID: 33824593
[TBL] [Abstract][Full Text] [Related]
15. SMARCA4-deficient Sinonasal Carcinoma.
Agaimy A; Weichert W
Head Neck Pathol; 2017 Dec; 11(4):541-545. PubMed ID: 28176137
[TBL] [Abstract][Full Text] [Related]
16. SMARCB1 (INI-1)-deficient Sinonasal Carcinoma: A Series of 39 Cases Expanding the Morphologic and Clinicopathologic Spectrum of a Recently Described Entity.
Agaimy A; Hartmann A; Antonescu CR; Chiosea SI; El-Mofty SK; Geddert H; Iro H; Lewis JS; Märkl B; Mills SE; Riener MO; Robertson T; Sandison A; Semrau S; Simpson RH; Stelow E; Westra WH; Bishop JA
Am J Surg Pathol; 2017 Apr; 41(4):458-471. PubMed ID: 28291122
[TBL] [Abstract][Full Text] [Related]
17. Cytopathologic features of SMARCB1 (INI-1)-deficient sinonasal carcinoma.
Allard FD; Bell D; Stelow EB
Cancer Cytopathol; 2018 Aug; 126(8):567-574. PubMed ID: 29797680
[TBL] [Abstract][Full Text] [Related]
18. SMARCB1 deficient sinonasal carcinoma: An emerging entity with a diagnostic challenge.
Anila KR; Ginju V; Vishnu VL; Kumar R; Jayasree K
Indian J Pathol Microbiol; 2023; 66(1):159-161. PubMed ID: 36656230
[TBL] [Abstract][Full Text] [Related]
19. A Case of SMARCB1-Deficient Sinonasal Carcinoma With Clear Cell Morphology.
Tamaki T; Teruya K; Hirakawa H; Tomita M; Wada N
Cureus; 2024 May; 16(5):e59684. PubMed ID: 38836164
[TBL] [Abstract][Full Text] [Related]
20. INI-1-Deficient Sinonasal Carcinoma: Case Report with Emphasis on Differential Diagnosis.
Alsayed AM; Aljufairi EA; Alshammari AO; Alsindi KA; Sabra OA
Case Rep Pathol; 2022; 2022():5629984. PubMed ID: 35399302
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
